Clinical Roundup Vectibix superior to bevacizumab in Japanese patients with wild-type RAS mCRC June 10, 2022Vol.48 No.23
Clinical Roundup Cedars-Sinai study shows racial and ethnic disparities in access to immunotherapy for advanced liver cancer June 10, 2022Vol.48 No.23
Clinical Roundup ACS study: Pandemic reduced breast, cervical, colorectal cancer screenings by millions in 2020 June 10, 2022Vol.48 No.23
Clinical Roundup ACS study: Public perception of e-cigarettes vs. cigarettes harms changed sharply during EVALI epidemic and COVID-19 pandemic June 10, 2022Vol.48 No.23
Drugs & Targets Parker Institute for Cancer Immunotherapy, Resilience partner to develop cell and gene therapies June 10, 2022Vol.48 No.23
Drugs & Targets Dana-Farber, Gustave Roussy, L’Institut Servier sign oncology cooperation agreement June 10, 2022Vol.48 No.23
Drugs & Targets FDA campaign aims to prevent e-cigarette use among AI/AN youth June 10, 2022Vol.48 No.23
Conversation with The Cancer Letter ATOM Coalition sees patent sharing as key to overcoming scarcity of cancer drugs in LLMICs June 03, 2022Vol.48 No.22By Alice Tracey
In Brief Emory Winship receives $11M NCI grant to improve immunotherapy for lung cancer June 03, 2022Vol.48 No.22
